MARKET

BNR

BNR

Burning Rock Biotech Ltd
NASDAQ
0.7600
0.0000
0.00%
Closed 15:58 04/12 EDT
OPEN
0.7300
PREV CLOSE
0.7600
HIGH
0.8049
LOW
0.7300
VOLUME
25.59K
TURNOVER
0
52 WEEK HIGH
3.250
52 WEEK LOW
0.5722
MARKET CAP
78.03M
P/E (TTM)
-0.8452
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at BNR last week (0401-0405)?
Weekly Report · 6d ago
Weekly Report: what happened at BNR last week (0325-0329)?
Weekly Report · 04/01 12:13
Burning Rock Biotech GAAP EPS of -$0.22, revenue of $17.1M
Burning Rock Biotech reported Q4 GAAP EPS of -$0.22, revenue of $17.1M. The company expects to achieve breakeven in the first half of 2024. Cash, cash equivalents, restricted cash were $86.7 million as of December 31, 2023.
Seeking Alpha · 03/29 06:47
BNR Stock Earnings: Burning Rock Biotech Reported Results for Q4 2023
Burning Rock Biotech just reported results for the fourth quarter of 2023. The company reported earnings per share of -22 cents and revenue of $17.05 million. InvestorPlace Earnings is a project that automates coverage of quarterly earnings reports to help readers understand the figures.
Investorplace · 03/29 02:52
Burning Rock Biotech’s 2023 Financial Dynamics
TipRanks · 03/28 22:27
Burning Rock Biotech Q4 EPS $(0.22) Up From $(0.31) YoY, Sales $17.10M Down From $20.62M YoY
Burning Rock Biotech reported quarterly losses of $0.22 per share. The company reported $17.10 million in sales for the quarter. This is a 17.08 percent decrease over sales of $20.62 million in the same period last year .
Benzinga · 03/28 21:23
Weekly Report: what happened at BNR last week (0318-0322)?
Weekly Report · 03/25 12:16
Earnings week ahead: Walgreens Boots Alliance, Carnival, GameStop and more
Several key companies are set to release their earnings reports for the week of March 25 to 29. Walgreens Boots Alliance, Carnival, GameStop and more are among the companies scheduled to report next week. The week is shortened by a market holiday on Friday and will be shortened to one day.
Seeking Alpha · 03/24 12:01
More
About BNR
Burning Rock Biotech Ltd is a holding company mainly engaged in the next generation sequencing (NGS) based cancer therapy selection. The Company operates three segments. Central Laboratory Business segment is engaged in the sales of cancer therapy selection test to individual patients. In-Hospital Business segment is engaged in the sales of reagent kits and the provision of the facilitation services for the sale of laboratory equipment to hospitals. Pharma Research and Development Services segment provide services to companies primarily in relation to the development of targeted therapies and immunotherapies for various types of cancer, and to hospitals for their studies on cancer diagnosis and treatment. Its products include OncoScreen Plus and LungPlasma. Its NGS-based cancer therapy selection tests applicable to a broad range of cancer types, including lung cancer, prostate cancer, breast cancer and others. The Company mainly conducts its businesses in the China market.

Webull offers Burning Rock Biotech Ltd (ADR) stock information, including NASDAQ: BNR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BNR stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BNR stock methods without spending real money on the virtual paper trading platform.